License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals makes the process as quick and easy as possible.

Use our technology explorer to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.
 

Technology Keywords
Color Sandbox: Smart Swatch Builder Software , Computer Graphics , Animation , Neural Networks , Deep Learning , Artificial Intelligence (AI) , Machine Learning 
Recombinant Antibodies Network (RAN) Antibodies , Cancer , Advanced Health Technologies , Biotechnology , Pharmaceuticals , Therapeutics 
Using Glucose Meter As a Molecular Interface for Point-Of-Care Diagnostics Point-of-Care , Covid-19 , Diagnostics , Molecular Detection , Synthetic Biology , SARS-COV-2 
Integrated Quantum Dot Barcode Smartphone Optical Device for Diagnosis of COVID-19 Covid-19 , Point-of-Care , Nanomaterials and Nanoparticles , Quantum Dots , Portable Diagnostics , Patient Care , Semiconductors , Medical Devices , Cartridge 
Immunotyping COVID-19 Patients Using Novel Protein Complementation-Based Assay Covid-19 , Diagnostics , Protein-Protein Interactions , Infectious Diseases , Clinical Tests , Pandemic , Immunoassay , SARS-COV-2 , Virus , Antibodies 
Rapid, remote vital sign monitoring and screening Advanced Health Technologies , Covid-19 , Remote monitoring , Patient Care , Biometrics , Biomedical engineering , Biomedical Imaging , Biosensor , Software , 3D imaging , Image and video processing , Screening 
Human Culture Assay to Assess Muscle Stem Cell Potency Regenerative Medicine , stem cells , Stem cell-mediated repair , Muscular Dystrophy , Cell Therapy 
Novel Substrates for Chemically Defined Culture of Human Pluripotent Stem Cells stem cell culture , pluripotent , Regenerative Medicine , stem cells , tissue culture reagents , Biomaterials 
ODAIA: AI-Driven Customer Journey Intelligence Data Analytics , Artificial Intelligence (AI) , Software , Companies , Research Tools 
Novel Counter-Measure Against Nerve Gas & Other Organophosphate/Carbamate Poisoning Advanced Health Technologies , Drug Discovery , Health & Related Life Sciences , molecular mechanisms , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Small Molecules 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515
Radio Options- Did you find this useful?
Did you find this useful?
Let us know if you found this page useful. Did you find the information you were looking for?